S&P 500   4,641.73 (-0.29%)
DOW   34,934.91 (-0.57%)
QQQ   400.60 (+0.23%)
AAPL   164.00 (+2.35%)
MSFT   337.48 (+0.25%)
FB   334.07 (-1.17%)
GOOGL   2,916.38 (+0.20%)
AMZN   3,572.84 (+0.32%)
TSLA   1,164.95 (+2.46%)
NVDA   330.92 (-0.85%)
BABA   129.92 (-1.28%)
NIO   40.68 (+0.54%)
CGC   10.89 (-1.54%)
AMD   163.37 (+0.90%)
GE   96.38 (-2.05%)
MU   86.21 (+0.08%)
T   23.13 (-3.18%)
F   19.58 (-0.46%)
DIS   145.64 (-1.47%)
ACB   6.42 (-0.31%)
AMC   35.81 (-2.80%)
PFE   53.43 (+1.97%)
BA   196.11 (-1.20%)
S&P 500   4,641.73 (-0.29%)
DOW   34,934.91 (-0.57%)
QQQ   400.60 (+0.23%)
AAPL   164.00 (+2.35%)
MSFT   337.48 (+0.25%)
FB   334.07 (-1.17%)
GOOGL   2,916.38 (+0.20%)
AMZN   3,572.84 (+0.32%)
TSLA   1,164.95 (+2.46%)
NVDA   330.92 (-0.85%)
BABA   129.92 (-1.28%)
NIO   40.68 (+0.54%)
CGC   10.89 (-1.54%)
AMD   163.37 (+0.90%)
GE   96.38 (-2.05%)
MU   86.21 (+0.08%)
T   23.13 (-3.18%)
F   19.58 (-0.46%)
DIS   145.64 (-1.47%)
ACB   6.42 (-0.31%)
AMC   35.81 (-2.80%)
PFE   53.43 (+1.97%)
BA   196.11 (-1.20%)
S&P 500   4,641.73 (-0.29%)
DOW   34,934.91 (-0.57%)
QQQ   400.60 (+0.23%)
AAPL   164.00 (+2.35%)
MSFT   337.48 (+0.25%)
FB   334.07 (-1.17%)
GOOGL   2,916.38 (+0.20%)
AMZN   3,572.84 (+0.32%)
TSLA   1,164.95 (+2.46%)
NVDA   330.92 (-0.85%)
BABA   129.92 (-1.28%)
NIO   40.68 (+0.54%)
CGC   10.89 (-1.54%)
AMD   163.37 (+0.90%)
GE   96.38 (-2.05%)
MU   86.21 (+0.08%)
T   23.13 (-3.18%)
F   19.58 (-0.46%)
DIS   145.64 (-1.47%)
ACB   6.42 (-0.31%)
AMC   35.81 (-2.80%)
PFE   53.43 (+1.97%)
BA   196.11 (-1.20%)
S&P 500   4,641.73 (-0.29%)
DOW   34,934.91 (-0.57%)
QQQ   400.60 (+0.23%)
AAPL   164.00 (+2.35%)
MSFT   337.48 (+0.25%)
FB   334.07 (-1.17%)
GOOGL   2,916.38 (+0.20%)
AMZN   3,572.84 (+0.32%)
TSLA   1,164.95 (+2.46%)
NVDA   330.92 (-0.85%)
BABA   129.92 (-1.28%)
NIO   40.68 (+0.54%)
CGC   10.89 (-1.54%)
AMD   163.37 (+0.90%)
GE   96.38 (-2.05%)
MU   86.21 (+0.08%)
T   23.13 (-3.18%)
F   19.58 (-0.46%)
DIS   145.64 (-1.47%)
ACB   6.42 (-0.31%)
AMC   35.81 (-2.80%)
PFE   53.43 (+1.97%)
BA   196.11 (-1.20%)
NASDAQ:BDSX

Biodesix Insider Trades

$6.34
+0.08 (+1.28%)
(As of 11/30/2021 09:30 AM ET)
Add
Compare
Today's Range
$6.34
$6.34
50-Day Range
$6.05
$8.97
52-Week Range
$5.73
$31.99
Volume
100 shs
Average Volume
91,610 shs
Market Capitalization
$171.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A

Biodesix (NASDAQ:BDSX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
53.40%

Number Of
Insiders Buying
(Last 12 Months)
4

Amount Of
Insider Buying
(Last 12 Months)
$3.02 M

Number Of
Insiders Selling
(Last 12 Months)
0

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get BDSX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Biodesix stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Biodesix (NASDAQ BDSX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/19/2021Jack W SchulerDirectorBuy60,000$6.50$390,000.00  
11/18/2021John PatienceChairmanBuy9,497$6.34$60,210.98  
11/17/2021Jack W SchulerDirectorBuy20,000$6.51$130,200.00  
11/17/2021Robin Harper CowieCFOBuy1,000$6.51$6,510.00  
11/17/2021Scott HuttonCEOBuy3,000$6.46$19,380.00  
8/19/2021Jack W SchulerDirectorBuy50,000$7.69$384,500.00  
8/19/2021John PatienceChairmanBuy8,396$8.04$67,503.84  
8/17/2021Jack W SchulerDirectorBuy29,440$7.18$211,379.20  
8/17/2021John PatienceChairmanBuy1,604$7.12$11,420.4858,597  
8/13/2021Jack W SchulerDirectorBuy232,000$7.50$1,740,000.00  
(Data available from 1/1/2013 forward)












Biodesix (NASDAQ:BDSX) Insider Trade Frequently Asked Questions

Who is on Biodesix's Insider Roster?

What percentage of Biodesix stock is owned by insiders?

53.40% of Biodesix stock is owned by insiders. Learn more on BDSX's insider holdings

Which Biodesix insiders have been buying company stock?

The following insiders have purchased Biodesix stock in the last 24 months: Jack W Schuler ($2,856,079.20), John Patience ($139,135.30), Robin Harper Cowie ($6,510.00), and Scott Hutton ($19,380.00).

How much insider buying is happening at Biodesix?

Insiders have purchased a total of 414,937 Biodesix shares in the last 24 months for a total of $3,021,104.50 bought.

This page was last updated on 11/30/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.